Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: capitalistbeatnik who wrote (974)	3/15/1999 4:34:00 PM
From: Feathered Propeller	Read Replies (1) \| Respond to of 1754

CNBC/Squawk Box/Tuesday/9:10am/VISX/3-16-99

To: capitalistbeatnik who wrote (974)	3/16/1999 10:46:00 AM
From: Vector1	Read Replies (2) \| Respond to of 1754

VISX is down this morning because of a PW downgrade. The following is an excerpt VISX: Downgrading to Neutral on Price of $90-95 within the last few trading days. At these levels, we believe the stock may be vulnerable to profit taking. * After meeting with VISX management on March 12, our sense is that business fundamentals remain particularly healthy. We continue to look for the company to have an excellent first-quarter showing ($0.54 versus $0.23 a year ago), reflecting strong equipment sales and robust license fee revenue. * Despite our downgrade, we remain very bullish on the prospects for the LVC industry and believe that VISX is extremely well positioned to leverage its growth. Domestically, we continue to look for the industry to perform about 800,000 LVC procedures in 1999 and 1.1-1.2 million procedures next year.